BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 17654125)

  • 1. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
    Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
    J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary therapy in asthma: inhaled corticosteroids and what?
    Bjermer L; Diamant Z
    Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Caution recommended in prescribing long-acting beta2-adrenergic agonists to patients with asthma].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):889-91. PubMed ID: 16686087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.
    Nelson HS; Carr W; Nathan R; Portnoy JM
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):11-5. PubMed ID: 19205279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in response to asthma medications.
    Tamesis GP; Krawiec ME
    Curr Opin Allergy Clin Immunol; 2007 Apr; 7(2):185-9. PubMed ID: 17351474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
    ten Hacken NH; Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating combination therapies for asthma: pros, cons, and comparative benefits.
    Bjermer L
    Ther Adv Respir Dis; 2008 Jun; 2(3):149-61. PubMed ID: 19124367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of antileukotriene use in asthma management.
    Polosa R
    Curr Opin Pulm Med; 2007 Jan; 13(1):24-30. PubMed ID: 17133121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting beta-2 agonists in asthma.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):1-2. PubMed ID: 19122566
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of asthma in preschool children with inhaled corticosteroids and leukotriene receptor antagonists.
    Bacharier LB
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):158-62. PubMed ID: 18317026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A safety review of long-acting beta2-agonists in patients with asthma.
    Rider NL; Craig TJ
    J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
    Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
    Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "As-required" combination therapy with inhaled corticosteroids and long-acting beta-2 agonists for asthma: current evidence and recommendations.
    Taylor DR; Jayaram L; Asher MI; Epton MJ
    N Z Med J; 2008 Nov; 121(1285):106-18. PubMed ID: 19079443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma update: Part II. Medical management.
    Mintz M
    Am Fam Physician; 2004 Sep; 70(6):1061-6. PubMed ID: 15456115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.